Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Transl Med ; 6(258): 258ra140, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25320232

ABSTRACT

During critical periods of development, the brain easily changes in response to environmental stimuli, but this neural plasticity declines by adulthood. By acutely disrupting paired immunoglobulin-like receptor B (PirB) function at specific ages, we show that PirB actively represses neural plasticity throughout life. We disrupted PirB function either by genetically introducing a conditional PirB allele into mice or by minipump infusion of a soluble PirB ectodomain (sPirB) into mouse visual cortex. We found that neural plasticity, as measured by depriving mice of vision in one eye and testing ocular dominance, was enhanced by this treatment both during the critical period and when PirB function was disrupted in adulthood. Acute blockade of PirB triggered the formation of new functional synapses, as indicated by increases in miniature excitatory postsynaptic current (mEPSC) frequency and spine density on dendrites of layer 5 pyramidal neurons. In addition, recovery from amblyopia--the decline in visual acuity and spine density resulting from long-term monocular deprivation--was possible after a 1-week infusion of sPirB after the deprivation period. Thus, neural plasticity in adult visual cortex is actively repressed and can be enhanced by blocking PirB function.


Subject(s)
Amblyopia/physiopathology , Dendritic Spines/metabolism , Neuronal Plasticity , Receptors, Immunologic/metabolism , Synapses/metabolism , Up-Regulation , Visual Cortex/physiopathology , Amblyopia/metabolism , Animals , Animals, Newborn , Dendritic Spines/drug effects , Dominance, Ocular/drug effects , Gene Deletion , Genotype , Integrases/metabolism , Ligands , Mice , Neuronal Plasticity/drug effects , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Recovery of Function/drug effects , Synapses/drug effects , Tamoxifen/pharmacology , Up-Regulation/drug effects , Visual Acuity/drug effects , Visual Cortex/drug effects
2.
Science ; 322(5903): 967-70, 2008 Nov 07.
Article in English | MEDLINE | ID: mdl-18988857

ABSTRACT

A major barrier to regenerating axons after injury in the mammalian central nervous system is an unfavorable milieu. Three proteins found in myelin--Nogo, MAG, and OMgp--inhibit axon regeneration in vitro and bind to the glycosylphosphatidylinositol-anchored Nogo receptor (NgR). However, genetic deletion of NgR has only a modest disinhibitory effect, suggesting that other binding receptors for these molecules probably exist. With the use of expression cloning, we have found that paired immunoglobulin-like receptor B (PirB), which has been implicated in nervous system plasticity, is a high-affinity receptor for Nogo, MAG, and OMgp. Interfering with PirB activity, either with antibodies or genetically, partially rescues neurite inhibition by Nogo66, MAG, OMgp, and myelin in cultured neurons. Blocking both PirB and NgR activities leads to near-complete release from myelin inhibition. Our results implicate PirB in mediating regeneration block, identify PirB as a potential target for axon regeneration therapies, and provide an explanation for the similar enhancements of visual system plasticity in PirB and NgR knockout mice.


Subject(s)
Axons/physiology , Myelin Proteins/metabolism , Nerve Regeneration , Neurons/cytology , Neurons/metabolism , Receptors, Immunologic/metabolism , Amino Acid Sequence , Animals , Cells, Cultured , Cerebellum/cytology , GPI-Linked Proteins , Ganglia, Spinal/cytology , Growth Cones/physiology , Mice , Molecular Sequence Data , Myelin-Associated Glycoprotein/metabolism , Myelin-Oligodendrocyte Glycoprotein , Neurites/physiology , Nogo Proteins , Nogo Receptor 1 , Receptors, Cell Surface/metabolism , Receptors, Immunologic/genetics , Sensory Receptor Cells/cytology , Sensory Receptor Cells/metabolism
3.
Science ; 313(5794): 1795-800, 2006 Sep 22.
Article in English | MEDLINE | ID: mdl-16917027

ABSTRACT

Experience can alter synaptic connectivity throughout life, but the degree of plasticity present at each age is regulated by mechanisms that remain largely unknown. Here, we demonstrate that Paired-immunoglobulin-like receptor B (PirB), a major histocompatibility complex class I (MHCI) receptor, is expressed in subsets of neurons throughout the brain. Neuronal PirB protein is associated with synapses and forms complexes with the phosphatases Shp-1 and Shp-2. Soluble PirB fusion protein binds to cortical neurons in an MHCI-dependent manner. In mutant mice lacking functional PirB, cortical ocular-dominance plasticity is more robust at all ages. Thus, an MHCI receptor is expressed in central nervous system neurons and functions to limit the extent of experience-dependent plasticity in the visual cortex throughout life. PirB is also expressed in many other regions of the central nervous system, suggesting that it may function broadly to stabilize neural circuits.


Subject(s)
Dominance, Ocular/physiology , Neuronal Plasticity , Receptors, Immunologic/physiology , Synapses/physiology , Visual Cortex/physiology , Aging , Animals , Brain/metabolism , Cells, Cultured , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Histocompatibility Antigens Class I/metabolism , In Situ Hybridization , Intracellular Signaling Peptides and Proteins/metabolism , Mice , Mice, Inbred C57BL , Mutation , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Phosphorylation , Protein Binding , Protein Structure, Tertiary , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/metabolism , Receptors, Immunologic/chemistry , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolism , Recombinant Fusion Proteins/metabolism , Synapses/metabolism
4.
Proc Natl Acad Sci U S A ; 100(22): 13048-53, 2003 Oct 28.
Article in English | MEDLINE | ID: mdl-14569018

ABSTRACT

MHC class I proteins are cell-surface ligands that bind to T cell receptors and other immunoreceptors and act to regulate the activation state of immune cells. Recent work has shown that MHC class I genes and CD3zeta, an obligate component of T cell receptors, are expressed in neurons, are regulated by neuronal activity, and function in neuronal development and plasticity. A search for additional neuronally expressed T cell receptor components has revealed that the T cell antigen receptor beta (TCRbeta) locus is expressed in neurons of the murine central nervous system and that this expression is dynamically regulated over development. In neonates, expression is most abundant in various thalamic nuclei. At later ages and in adults, thalamic expression fades and cortical expression is robust, particularly in layer 6. In T cells, protein-encoding transcripts are produced only after recombination of the TCRbeta genomic locus, which joins variable, diversity, and joining regions, a process that creates much of the diversity of the immune system. We detect no genomic recombination in neurons. Rather, transcripts begin in regions upstream of several joining regions, and are spliced to constant region segments. One of the transcripts encodes a hypothetical 207-aa, 23-kDa protein, which includes the TCRbeta J2.7 region, and the entire C region. These observations suggest that TCRbeta may function in neurons.


Subject(s)
Brain/immunology , Gene Expression Regulation/immunology , Genes, T-Cell Receptor beta/genetics , Neurons/immunology , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cerebellum/immunology , Cerebral Cortex/immunology , Chromosome Mapping , DNA Primers , Histocompatibility Antigens Class I/immunology , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Spleen/immunology , Thalamus/immunology
5.
Oncogene ; 22(30): 4636-41, 2003 Jul 24.
Article in English | MEDLINE | ID: mdl-12879007

ABSTRACT

We previously described two human DnaJ proteins, hTid-1L and hTid-1S, which are derived from alternative splicing of the TID1 gene, the human homologue of the Drosophila tumor suppressor lethal(2) tumorous imaginal discs, and showed that hTid-1L promoted while hTid-1S antagonized apoptosis. There are two subsets of helper T cells, Th1 and Th2, of which Th2 cells are significantly less prone to apoptosis induced by stimulation through the T-cell receptor. This apoptotic process is known as activation-induced cell death (AICD). The molecular basis for the differential susceptibility of Th1 and Th2 cells to AICD is not known. Here we show that the antiapoptotic variant, Tid-1S, is selectively induced in murine Th2 cells following activation. Expression of a dominant-negative mutant of hTid-1S in a Th2 cell line strikingly enhanced activation of caspase 3 in response to CD3 stimulation, and caused the cells to become sensitive to AICD. Hence, the accumulation of Tid-1S in Th2 cells following activation represents a novel mechanism that may contribute to the induction of apoptosis resistance during the activation of Th2 cells.


Subject(s)
Heat-Shock Proteins/metabolism , Heat-Shock Proteins/physiology , Th2 Cells/pathology , Amino Acid Sequence , Animals , Apoptosis , Caspase 3 , Caspases/metabolism , Cell Death , Cell Differentiation , Cell Line , Electrophoresis, Polyacrylamide Gel , Genes, Dominant , HSP40 Heat-Shock Proteins , Humans , Jurkat Cells , Mice , Molecular Sequence Data , Th1 Cells , Th2 Cells/metabolism , Time Factors , Transfection , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...